Publications by authors named "Caleb Ho"

Claim this Profile
P
Plasma Cell Leukemia: Genomic Features and Their Potential Relevance for Exploring Clinical Actionability.
Meera Mohan, Natalie Danziger, Othman Salim Akhtar, Ravi Narra, Marcelo C Pasquini, Caleb Ho

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients.
Mark Y Jeng, Phillip Wong, Jessica R Flynn, Erika Ritter, Caleb Ho

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic mutations in STAG2 are associated with separated megakaryocyte nuclear lobes in myelodysplastic syndromes.
Waihay J Wong, Rebecca L Zon, Christopher J Gibson, Caleb Ho, Olga Pozdnyakova, Zuzana Tothova

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Specificity Detection of UV Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors Using FoundationOne Liquid CDx.
Douglas A Mata, Angela A Kou, Andreas M Heilmann, Julius Honecker, Benjamin R Kroger, Thomas Wieland, Caleb Ho, Lauren L Ritterhouse

J Mol Diagn· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Genomic Analysis of Nucleophosmin (NPM1) in Acute Myeloid Leukemia.
Osama Batayneh, Mahmoudreza Moein, Alexandra Goodman, Devashish Desai, Dean Pavlick, Caleb Ho, Zheng Zhou

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study.
William G Wierda, Nirav N Shah, Chan Y Cheah, David Lewis, Marc S Hoffmann, Joanna M Rhodes, Philip A Thompson, Caleb Ho

Lancet Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Caleb Ho

Haematologica· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation.
Zachary D Epstein-Peterson, Esther Drill, Umut Aypar, Connie Lee Batlevi, Philip Caron, Caleb Ho

Haematologica· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
Ying Liu, Caleb Ho, Wayne Yu, Ying Huang, Jeffrey Miller

J Mol Diagn· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.
Kseniya Petrova-Drus, Mustafa Syed, Wayne Yu, Kasey Hutt, Alyssa M Zlotnicki, Caleb Ho, Anthony Mato

J Mol Diagn· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures.
Benjamin Diamond, Bachisio Ziccheddu, Kylee Maclachlan, Justin Taylor, Eileen Boyle, Namrata Chandhok, Caleb Ho

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation Sequencing.
Kseniya Petrova-Drus, Andrés E Quesada, Anita S Bowman, Ryan Ptashkin, Jinjuan Yao, Caleb Ho

J Mol Diagn· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas.
Shenon Sethi, Zachary Epstein-Peterson, Anita Kumar, Caleb Ho

Front Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing-Based Antigen-Receptor Gene Clonality Assays: Will They Become the Clinical Standard?
Caleb Ho, Paul G Rothberg

J Mol Diagn· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m ) in combination with lenalidomide and dexamethasone.
Neha Korde, Donna Mastey, Elizabet Tavitian, Sham Mailankody, Alexander Lesokhin, Oscar Lahoud, Caleb Ho

Am J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Ola Landgren, Malin Hultcrantz, Benjamin Diamond, Alexander M Lesokhin, Sham Mailankody, Oscar B Lahoud, Katie Thoren, Caleb Ho

JAMA Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial.
Benjamin Diamond, Neha Korde, Alexander M Lesokhin, Eric L Smith, Urvi Shah, Oscar Lahoud, Katie Thoren, Caleb Ho

Lancet Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway.
Andrés E Quesada, Yanming Zhang, Ryan Ptashkin, Caleb Ho, Steven Horwitz

Breast J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic use.
Kylee H Maclachlan, Neil Came, Benjamin Diamond, Mikhail Roshal, Caleb Ho, Katie Thoren, Marius E Mayerhoefer

Pathology· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the undetectable: The current landscape of minimal residual disease assessment in multiple myeloma and goals for future clarity.
Benjamin T Diamond, Even Rustad, Kylee Maclachlan, Katie Thoren, Caleb Ho

Blood Rev· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.
Caleb Ho, Mustafa Syed, Mikhail Roshal, Kseniya Petrova-Drus, Christine Moung

J Mol Diagn· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.
Justin Taylor, Mark Ta Donoghue, Caleb Ho, Kseniya Petrova-Drus, Hikmat A Al-Ahmadie

J Clin Invest· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor.
Ken Naganuma, Alexander Chan, Yanming Zhang, Natasha Lewis, Wenbin Xiao, Caleb Ho

J Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.
David Sermer, Connie Batlevi, M Lia Palomba, Gunjan Shah, Richard J Lin, Caleb Ho, Steven Horwitz

Blood Adv· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment.
Malin Hultcrantz, Even Holth Rustad, Venkata Yellapantula, Maria Arcila, Caleb Ho

Blood Cancer J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis